Newsletter: Vol 9, No. 1, September 2025

In this issue, read about ongoing research into ulipristal acetate as an alternative option for medication abortion and an analysis of patient experiences with asynchronous medication abortion care. Also read about our involvement in a regional conference focused on advancing access to self-care interventions for abortion and family planning, as well as a webinar presenting preliminary clinical evidence on ulipristal acetate for medication abortion to a Latin American audience.

Read the full Newsletter